Inactivation of human immunodeficiency virus (HIV)-1 envelope-specific CD8+ cytotoxic T lymphocytes by free antigenic peptide: a self-veto mechanism?
about
Counter-regulation of cytolytic activity and cytokine production in HIV-1-specific murine CD8+ cytotoxic T lymphocytes by free antigenic peptide.Suppression of murine tumour growth through CD8+ cytotoxic T lymphocytes via activated DEC-205+ dendritic cells by sequential administration of α-galactosylceramide in vivo.Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections.Induction of tumor-specific acquired immunity against already established tumors by selective stimulation of innate DEC-205(+) dendritic cells.Effect of the V3 loop deletion of envelope glycoprotein on cellular responses and protection against challenge with recombinant vaccinia virus expressing gp160 of primary human immunodeficiency virus type 1 isolates.Molecular analysis of TCR and peptide/MHC interaction using P18-I10-derived peptides with a single D-amino acid substitution.Models of T cell anergy: is there a common molecular mechanism?Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTLOral vaccination with modified vaccinia virus Ankara attached covalently to TMPEG-modified cationic liposomes overcomes pre-existing poxvirus immunity from recombinant vaccinia immunization.Inactivation of tumor-specific CD8⁺ CTLs by tumor-infiltrating tolerogenic dendritic cellsIdentification of an immunodominant mouse minor histocompatibility antigen (MiHA). T cell response to a single dominant MiHA causes graft-versus-host disease.α-Galactosylceramide-activated murine NK1.1(+) invariant-NKT cells in the myometrium induce miscarriages in mice.Inhibition of R5-tropic HIV type-1 replication in CD4⁺ natural killer T cells by γδ T lymphocytes.Analysis of the mechanism for extracellular processing in the presentation of human immunodeficiency virus-1 envelope protein-derived peptide to epitope-specific cytotoxic T lymphocytes.Ligation of major histocompatability complex (MHC) class I molecules on human T cells induces cell death through PI-3 kinase-induced c-Jun NH2-terminal kinase activity: a novel apoptotic pathway distinct from Fas-induced apoptosis.E-cadherin interactions are required for Langerhans cell differentiation.Induction of rapid apoptosis for class I MHC molecule-restricted CD8(+) HIV-1 gp160-specific murine activated CTLs by free antigenic peptide in vivo.In vitro modulation of activation antigens on human lymphocytes by beta-estradiol.Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells
P2860
Q31775839-0C4DC459-F69C-4B0B-8ADF-77C5B346F545Q33769744-6338E36E-A61F-4375-990D-ECB51A9FEA34Q33776155-D0605572-DCA7-45D9-875D-8CD881830516Q33814171-13EB7A94-7267-4AF5-9A45-6F603768CACCQ34999946-E278106A-D936-4106-B7E2-7CAA00DE62CDQ35781187-41DB6AEE-1352-47A0-8F04-A68C8383A41CQ36366967-CC4E0904-375B-4392-A07D-9ADE1DD62429Q36367150-F683F554-11A4-4F6C-915C-45B5F477A700Q36819089-F68F93D1-689C-4DD3-8206-972EED8A9D29Q37250817-902890F6-6DBA-49A0-BF22-EB1E4B405AADQ37358062-3979886B-F11B-4D89-881F-E0E2BA23F36BQ37384967-4C09946E-B6C3-45CA-A1D5-9E7A9F266772Q39324337-DD1F72E8-B62F-4438-B1C4-67E0ADDB628FQ40851948-93F947EA-0AA8-4B4B-AAA4-6E5C53973E98Q41951791-1063650F-9C87-4A4D-AF33-5DE48260F384Q42234383-034F7ABE-C0EE-4631-8E65-74DB2AEFCA95Q43505322-4DA9C13B-F9FF-47A0-B5A2-CC1522EB6373Q50539431-EE00F89F-3862-4AD8-A0C0-AF0A1890B615Q57463914-5EF3D213-8F2B-4D6F-A4B5-6FF4D63C06BE
P2860
Inactivation of human immunodeficiency virus (HIV)-1 envelope-specific CD8+ cytotoxic T lymphocytes by free antigenic peptide: a self-veto mechanism?
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Inactivation of human immunode ...... eptide: a self-veto mechanism?
@ast
Inactivation of human immunode ...... eptide: a self-veto mechanism?
@en
type
label
Inactivation of human immunode ...... eptide: a self-veto mechanism?
@ast
Inactivation of human immunode ...... eptide: a self-veto mechanism?
@en
prefLabel
Inactivation of human immunode ...... eptide: a self-veto mechanism?
@ast
Inactivation of human immunode ...... eptide: a self-veto mechanism?
@en
P2093
P2860
P356
P1476
Inactivation of human immunode ...... eptide: a self-veto mechanism?
@en
P2093
Berzofsky JA
Leggatt GR
Nakagawa Y
Takahashi H
Yokomuro K
P2860
P304
P356
10.1084/JEM.183.3.879
P407
P577
1996-03-01T00:00:00Z